NCT04391257 is a NA clinical trial of geko™ in Stroke, sponsored by Firstkind Ltd.

Who is sponsoring NCT04391257?

NCT04391257 is sponsored by Firstkind Ltd.

What drugs are being tested in NCT04391257?

Interventions in NCT04391257: geko™.

What condition does NCT04391257 study?

NCT04391257 studies Stroke, Wound Heal, Edema Leg, Cardiac Pacemaker Electrical Interference.

Is NCT04391257 still recruiting?

NCT04391257 is currently completed. Last updated 5 August 2022.

Last reviewed 2022-08-05 · How we verify

NCT04391257

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study of gekoTM Interaction With Cardiac Pacemakers

Completed NA Last updated 5 August 2022

What this trial tests

NA trial testing geko™ in Stroke in 28 participants. Completed in 25 November 2021.

Timeline

4 December 2020

Primary endpoint
25 November 2021

25 November 2021

Quick facts

Lead sponsor	Firstkind Ltd
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	sequential
Masking	none
Primary purpose	prevention
Enrollment	28
Start date	4 December 2020
Primary completion	25 November 2021
Estimated completion	25 November 2021
Sites	2 locations across United Kingdom

Drugs / interventions tested

geko™

Conditions studied

Stroke — all drugs for Stroke →
Wound Heal — all drugs for Wound Heal →
Edema Leg — all drugs for Edema Leg →
Cardiac Pacemaker Electrical Interference — all drugs for Cardiac Pacemaker Electrical Interference →

Sponsor

Firstkind Ltd

Who can join

18 and older, any sex, with Stroke or Wound Heal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The gekoTM device is a small disposable battery powered device that attaches to the lower leg near the knee and stimulates the common peroneal nerve, causing muscle contraction of the lower leg. This contraction increases blood flow and the device is used to treat several conditions including deep vein thrombosis and venous leg ulcers. There is evidence that some powered muscle stimulators and related devices can affect Cardiac Demand Pacemakers. This study is to ascertain if there is any such interaction between the gekoTM device and permanently implanted cardiac pacemakers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Stimulation of the Tibial nerve Repetitively to Improve Incontinence in Parkinson's Electronically (STRIPE trial): a randomised control trial of tibial nerve stimulation for bladder symptoms in Parkinson's disease using a self-contained wearable device.
Smith MD, Tenison E, Drake MJ, Ben-Shlomo Y, et al · · 2022 · cited 7× · PMID 36307874 · DOI 10.1186/s13063-022-06827-3

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Other Firstkind Ltd trials

Trials by the same sponsor.

NCT07197996 — The RETRAIN Trial Phase 2 · NA · recruiting
NCT05476913 — GEKO Venous Thromboembolism Prevention Study · NA · recruiting
NCT04927234 — Foot and Ankle Post-operative Oedema Management Using Geko™ · NA · completed
NCT05057793 — Efficacy Study for Geko Device in VLU Patients (Canada) · NA · terminated
NCT04309110 — Efficacy of Adhesive Strength of New Hydrogel Formulation · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04391257 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Firstkind Ltd
Last refreshed: 5 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04391257.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing